A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes
about
The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTsADP-ribosylation of arginine.Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathwayTesting the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic miceCalcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice.P2X7 on Mouse T Cells: One Channel, Many FunctionsThe Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid MiceMouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo.In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies.Nanobodies as modulators of inflammation: potential applications for acute brain injury.CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism.Interferon-γ Limits Diabetogenic CD8+ T-Cell Effector Responses in Type 1 Diabetes.Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity.Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple MyelomaThe Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus
P2860
Q26991574-AB7E9DF7-77AA-4512-9C34-BDFB0089C1A9Q34023226-10B90509-DE5E-404E-9BED-0BCCD92BBF2CQ34340613-AB219A72-255F-4A58-B24A-E41F3DCDDBF0Q34982496-6683D0F2-CF24-4BD6-AE50-2B19A77A81A9Q35590808-9902AF7C-4C5E-47ED-92E2-ECD18C5DF977Q35621886-55D86A58-48FE-4B73-857A-5B10A7719E90Q36075204-08F5C904-04FF-4CEB-A5C6-CD66F723A547Q36171037-13CB43EE-E25A-492E-92FD-5E10AA05BB73Q39024388-0020243A-AF40-4765-9318-5516FC4A486FQ42105969-5D1407FA-0854-4CD6-8E0E-2C8A493A640FQ49789227-E2B29E1F-25F7-407D-98CC-146AF342C873Q50332956-A9EDD754-CC15-43A8-856A-74F27A600BAAQ55025877-61B7EB23-513E-45A8-84D6-FEBD4CCF8123Q59128091-E0FB18C5-AD84-4189-99E5-CEE3E40FA8C9Q59133987-CE380951-0DAC-4356-999D-9389DC92FDB7
P2860
A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@ast
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@en
type
label
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@ast
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@en
prefLabel
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@ast
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@en
P2093
P2860
P50
P1476
A recombinant heavy chain anti ...... n inhibits autoimmune diabetes
@en
P2093
Björn Rissiek
David V Serreze
Felix Scheuplein
Friedrich Koch-Nolte
John P Driver
Yi-Guang Chen
P2860
P304
P356
10.1016/J.JAUT.2009.08.012
P577
2009-10-01T00:00:00Z